Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

978 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19-related Hospitalizations and Medical Encounters Among Adults in the United States.
Kopel H, Araujo AB, Bogdanov A, Zeng N, Winer I, Winer-Jones JP, Lu T, Marks MA, Bonafede M, Nguyen VH, Martin D, Mansi JA. Kopel H, et al. Among authors: bogdanov a. Open Forum Infect Dis. 2024 Nov 26;11(12):ofae695. doi: 10.1093/ofid/ofae695. eCollection 2024 Dec. Open Forum Infect Dis. 2024. PMID: 39691287 Free PMC article.
Relative Effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines and Homologous Boosting in Preventing COVID-19 in Adults in the US.
Hung Nguyen V, Boileau C, Bogdanov A, Sredl M, Bonafede M, Ducruet T, Chavers S, Rosen A, Martin D, Buck P, Esposito D, Van de Velde N, Mansi JA. Hung Nguyen V, et al. Among authors: bogdanov a. Open Forum Infect Dis. 2023 May 25;10(7):ofad288. doi: 10.1093/ofid/ofad288. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37496607 Free PMC article.
Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults with Underlying Medical Conditions in the United States.
Kopel H, Nguyen VH, Bogdanov A, Winer I, Boileau C, Ducruet T, Zeng N, Winer-Jones JP, Esposito DB, Bausch-Jurken M, Beck E, Bonafede M, Mansi JA. Kopel H, et al. Among authors: bogdanov a. Vaccines (Basel). 2024 Sep 27;12(10):1107. doi: 10.3390/vaccines12101107. Vaccines (Basel). 2024. PMID: 39460274 Free PMC article.
Relative Effectiveness of the MF59-Adjuvanted Influenza Vaccine Versus High-Dose Influenza Vaccine in Older Adults With Influenza Risk Factors During the 2019-2020 US Influenza Season.
Imran M, Mills CW, McDermott KW, Dean A, Bogdanov A, McGovern I, Haag MDM. Imran M, et al. Among authors: bogdanov a. Open Forum Infect Dis. 2024 Aug 16;11(8):ofae459. doi: 10.1093/ofid/ofae459. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39170829 Free PMC article.
Relative Vaccine Effectiveness of Cell- vs Egg-Based Quadrivalent Influenza Vaccine Against Test-Confirmed Influenza Over 3 Seasons Between 2017 and 2020 in the United States.
Stein AN, Mills CW, McGovern I, McDermott KW, Dean A, Bogdanov AN, Sullivan SG, Haag MDM. Stein AN, et al. Among authors: bogdanov an. Open Forum Infect Dis. 2024 May 2;11(5):ofae175. doi: 10.1093/ofid/ofae175. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38698895 Free PMC article.
978 results